These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1458493)

  • 21. Secondary neoplasms following treatment for brain tumors.
    Weinstein JL; Ayyanar K; Watral MA
    Cancer Treat Res; 2009; 150():239-73. PubMed ID: 19834673
    [No Abstract]   [Full Text] [Related]  

  • 22. Neurological complications in children.
    Partap S; Fisher PG
    Cancer Treat Res; 2009; 150():133-43. PubMed ID: 19834666
    [No Abstract]   [Full Text] [Related]  

  • 23. Neurological complications in adults.
    Monje M; Wen PY
    Cancer Treat Res; 2009; 150():113-32. PubMed ID: 19834665
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemotherapy of pediatric brain-stem tumors.
    Fulton DS; Levin VA; Wara WM; Edwards MS; Wilson CB
    J Neurosurg; 1981 Jun; 54(6):721-5. PubMed ID: 6264050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total-body and red marrow dose estimates.
    Siegel JA; Stabin MG; Sparks RB
    J Nucl Med; 2003 Feb; 44(2):320-1; author reply 321-3. PubMed ID: 12571225
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II evaluation of topotecan for pediatric central nervous system tumors.
    Blaney SM; Phillips PC; Packer RJ; Heideman RL; Berg SL; Adamson PC; Allen JC; Sallan SE; Jakacki RI; Lange BJ; Reaman GH; Horowitz ME; Poplack DG; Balis FM
    Cancer; 1996 Aug; 78(3):527-31. PubMed ID: 8697400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined cytostatic treatment of malignant brain tumors (author's transl)].
    Heiss WD; Kroiss A; Kühböck J; Profanter W
    MMW Munch Med Wochenschr; 1974 Nov; 116(45):1957-60. PubMed ID: 4374657
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood-brain barrier and chemotherapeutic treatment of brain tumors.
    de Vries NA; Beijnen JH; Boogerd W; van Tellingen O
    Expert Rev Neurother; 2006 Aug; 6(8):1199-209. PubMed ID: 16893347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy for primary brain tumors.
    Allen JC
    Pediatr Ann; 1978 Dec; 7(12):81-5. PubMed ID: 740428
    [No Abstract]   [Full Text] [Related]  

  • 31. [Systemic therapy of cerebral metastases in breast carcinoma].
    Kreuser ED; Herrmann R; Krauseneck P; Mende S; Thiel E
    Dtsch Med Wochenschr; 1991 Aug; 116(31-32):1203-7. PubMed ID: 1860424
    [No Abstract]   [Full Text] [Related]  

  • 32. Auxologic and biochemical characterization of the three phases of growth failure in pediatric patients with brain tumors.
    Meacham LR; Mason PW; Sullivan KM
    J Pediatr Endocrinol Metab; 2004 May; 17(5):711-7. PubMed ID: 15237704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzumab-based therapy for metastatic breast cancer.
    Altundag K; Altundag O; Atik MA; Morandi P; Gunduz M
    Breast; 2005 Oct; 14(5):425. PubMed ID: 16216749
    [No Abstract]   [Full Text] [Related]  

  • 34. Radiation-Induced Cerebral Microbleeds in Pediatric Patients With Brain Tumors Treated With Proton Radiation Therapy.
    Kralik SF; Mereniuk TR; Grignon L; Shih CS; Ho CY; Finke W; Coleman PW; Watson GA; Buchsbaum JC
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1465-1471. PubMed ID: 30092336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combined treatment for malignant primitive brain tumors in infants using CCNU, neurosurgery and radiotherapy (author's transl)].
    Baldini M; Knerich R
    Ateneo Parmense Acta Biomed; 1976; 47(3):329-37. PubMed ID: 1016286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of ionizing radiation on the human brain: white matter and gray matter T1 in pediatric brain tumor patients treated with conformal radiation therapy.
    Steen RG; Koury B S M; Granja CI; Xiong X; Wu S; Glass JO; Mulhern RK; Kun LE; Merchant TE
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):79-91. PubMed ID: 11163500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant therapy for residual disease in children with medulloblastoma.
    Bloom HJ
    Recent Results Cancer Res; 1978; 68():412-22. PubMed ID: 111324
    [No Abstract]   [Full Text] [Related]  

  • 38. Central nervous system toxicity of cancer therapy in children.
    Moore IM
    J Pediatr Oncol Nurs; 1995 Oct; 12(4):203-10; discussion 211. PubMed ID: 7495525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical trial of MCNU for malignant brain tumors].
    Harada K; Okamoto H; Fujioka Y; Uozumi T; Kiya K; Kitaoka T; Goishi A; Sasaki U; Shima T; Inagawa T
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1423-31. PubMed ID: 2990350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review).
    van Vulpen M; Kal HB; Taphoorn MJ; El-Sharouni SY
    Oncol Rep; 2002; 9(4):683-8. PubMed ID: 12066192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.